Skip to main content
HR 2113 115th Congress House

Speeding Access to Already Approved Pharmaceuticals Act of 2017

Official title: To require the Food and Drug Administration to expedite review of pharmaceuticals that are approved for marketing in the European Union.

Introduced: May 16, 2017 See on congress.gov
Health Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationEurope
More subjectsShow fewer subjects
European UnionFood and Drug Administration (FDA)Prescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2017
Referred to the Subcommittee on Health.
Apr 20, 2017
Referred to the House Committee on Energy and Commerce.
Apr 20, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 21, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Speeding Access to Already Approved Pharmaceuticals Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Bacon, Don
Nebraska · May 16, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2113: Speeding Access to Already Approved Pharmaceuticals Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2113/
MLA
"H.R. 2113: Speeding Access to Already Approved Pharmaceuticals Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2113/.
Bluebook (legal)
H.R. 2113, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2113/.
Markdown link
[H.R. 2113: Speeding Access to Already Approved Pharmaceuticals Act of 2017](https://openamerica.io/bill/115-HR-2113/)
Report a problem